Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03373188
Title VX15/2503 and Immunotherapy in Resectable Pancreatic and Colorectal Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Emory University
Indications

pancreatic adenocarcinoma

colorectal adenocarcinoma

Therapies

Nivolumab + Pepinemab

Ipilimumab + Pepinemab

Pepinemab

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.